These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2703850)

  • 41. Relationship between structure and drug-induced parkinsonism.
    Sawada Y; Nasu R; Matsuo H; Ohtani H
    Ann Pharmacother; 2000 May; 34(5):668. PubMed ID: 10852100
    [No Abstract]   [Full Text] [Related]  

  • 42. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine.
    Sørensen PS; Hansen K; Olesen J
    Cephalalgia; 1986 Mar; 6(1):7-14. PubMed ID: 3516409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The value of flunarizine in the treatment of tinnitus.
    Hulshof JH; Vermeij P
    ORL J Otorhinolaryngol Relat Spec; 1986; 48(1):33-6. PubMed ID: 3513083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parkinson-like side effects during prolonged treatment with flunarizine.
    Di Rosa AE; Morgante L; Meduri M; Musolino R; Leggiadro N; Coraci M; Crisafulli A; Di Perri R
    Funct Neurol; 1987; 2(1):47-50. PubMed ID: 3315874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flunarizine: a wide spectrum prophylactic for migraine headache.
    Micieli G; Sances G; Pacchetti C; Trucco M; Magri M; Piazza D
    Int J Clin Pharmacol Res; 1984; 4(3):239-45. PubMed ID: 6490242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of vertebrobasilar insufficiency with flunarizine (author's transl)].
    Hofferberth B
    Arzneimittelforschung; 1980; 30(10):1817-9. PubMed ID: 7192120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flunarizine in vertigo. A double-blind placebo-controlled cross-over evaluation of a constant-dose schedule.
    Oosterveld WJ
    ORL J Otorhinolaryngol Relat Spec; 1982; 44(2):72-80. PubMed ID: 7041040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flunarizine in common migraine: Italian cooperative trial. I. Short-term results and responders' definition.
    Manzoni GC; Bono G; Sacquegna T; Manna V; Lanfranchi M; Micieli G; Cortelli P; Agnoli A
    Cephalalgia; 1985 May; 5 Suppl 2():149-53. PubMed ID: 3893735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical double blind study with the calcium antagonist flunarizine cerebral circulatory disturbances].
    Eckmann F
    Arzneimittelforschung; 1985; 35(8):1276-9. PubMed ID: 3907638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extrapyramidal symptoms in a patient treated with fluvoxamine.
    Wils V
    J Neurol Neurosurg Psychiatry; 1992 Apr; 55(4):330-1. PubMed ID: 1583525
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cinarizine and Parkinson's disease. Double-blind placebo-controlled study].
    Martí Massó JF
    Neurologia; 1986; 1(2):55-7. PubMed ID: 3079110
    [No Abstract]   [Full Text] [Related]  

  • 52. Exacerbation of extrapyramidal symptoms with paroxetine.
    Arya DK; McKenzie J; Worrall N
    Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
    [No Abstract]   [Full Text] [Related]  

  • 53. Double-blind placebo-controlled studies with flunarizine in venous insufficiency.
    Roeckaerts F; Vanden Bussche G
    Angiology; 1980 Dec; 31(12):833-45. PubMed ID: 7008658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
    Frenken CW; Nuijten ST
    Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral toxicity of antipsychotic drugs.
    Van Putten T; Marder SR
    J Clin Psychiatry; 1987 Sep; 48 Suppl():13-9. PubMed ID: 2887552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice.
    Desmedt LK; Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1975 Sep; 25(9):1408-13. PubMed ID: 1242663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Extrapyramidal movement disorders following the use of flunarizine].
    Assmann VC; Perquin WV; Touw DJ
    Ned Tijdschr Geneeskd; 1988 Oct; 132(42):1940-3. PubMed ID: 3185792
    [No Abstract]   [Full Text] [Related]  

  • 58. Vasodilating effect of flunarizine in anesthetized dogs.
    Kato H; Kurihara J; Ishii K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):257-63. PubMed ID: 7224725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rabbit syndrome, antidepressant use, and cerebral perfusion SPECT scan findings.
    Fornazzari L; Ichise M; Remington G; Smith I
    J Psychiatry Neurosci; 1991 Nov; 16(4):227-9. PubMed ID: 1786266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extrapyramidal symptoms and flunarizine.
    Amery WK
    Funct Neurol; 1987; 2(3):363-4. PubMed ID: 3692277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.